The updated Bell Potter report also states:
We believe NEU is well placed to benefit from this heightened M&A interest in the orphan drug space and therefore do not rule out the possibility of the company being a takeover target as well.
The updated Bell Potter report also states: We believe NEU is...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.11 |
Change
-0.610(2.94%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $20.05 | $679.2K | 33.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2 | $20.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.11 | 36 | 2 |
View Market Depth
| Last trade - 10.47am 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |